As the closure of Silicon Valley Bank continues to reverberate throughout the financial world, biotech companies are strategizing.
KQED’s Lesley McClurg has more.
This article was originally published on WBUR.org.
Copyright 2023 NPR. To see more, visit https://www.npr.org.